clinical survery for drug adherence and satisfaction of rivaroxaban in non-valvelar patients with atrial fibrillation

clinical survery for drug adherence and satisfaction of rivaroxaban in non-valvelar patients with atrial fibrillation - CHikushi Anti-coagulation Trial for Xarelto

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027754

Enrollment

200

Registered

2017-06-15

Start date

2014-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-valvelar patients with atrial fibrillation

Interventions

Xarelto Tablets 15mg once a day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: non-valvelar patients with atrial fibrillateion 1)newly prescribed 2)exchange from warfarin appropriateness judged by each attending doctor

Exclusion criteria

Exclusion criteria: 1)patient without infurmed consent 2)HD patients or serrese renal failure 3)bleeding symptom 4)more than moderate hepatic dystunction 5)pregnant or suspected 6)in appropriateness judged by attendeing doctor

Design outcomes

Primary

Measure	Time frame
drug adherence and satisfaction	—

Countries

Japan

Contacts

Public ContactHidenori Urata

Fukuoka University Chikushi HOspital Cardiovascular internal medicine

uratah@fukuoka-u.ac.jp092-921-1011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026